[Retracted] Comprehensive Diagnostic Medical System Based on Notch1 Signaling Pathway to Inhibit the Growth of Small-Cell Lung Carcinoma

<table class="table-group" id="tab5"><tr><td><table class="table"><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td class="align_left">Organization type</td><td class="align_center">Egf17 mRNA</td><td class="align_center">Notch1 mRNA</td><td class="align_center">E-cadherin mRNA</td><td class="align_center">Vimentin mRNA</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td class="align_left">Normal lung tissue</td><td class="align_center">3.417 ± 0.76</td><td class="align_center">4.217 ± 1.27</td><td class="align_center">5.748 ± 0.72</td><td class="align_center">2.243 ± 0.73</td></tr><tr><td class="align_left">Lung cancer tissue</td><td class="align_center">6.88 ± 0.62</td><td class="align_center">6.791 ± 1.52</td><td class="align_center">3.403 ± 0.181</td><td class="align_center">5.812 ± 0.36</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Expression of Egf17, Notch1, E-cadherin, and vimentin mRNA in lung tissues of each group.</div>

Journal of Healthcare Engineering

tab5

Table 5

Table 5: [Retracted] Comprehensive Diagnostic Medical System Based on Notch1 Signaling Pathway to Inhibit the Growth of Small-Cell Lung Carcinoma 